Paradice Investment Management LLC Sells 97,427 Shares of Envista Holdings Corporation $NVST

Key Points

• Paradice Investment Management sold 97,427 shares of Envista, trimming its stake by 5.4% to 1,709,507 shares — the stock now represents about 7.2% of Paradice’s portfolio and is its third-largest holding (valued at ~$37.1M).
• Envista beat quarterly estimates with $0.38 EPS vs. $0.32 consensus and reported revenue up 15% year-over-year, and it issued FY2026 guidance of 1.350–1.450 EPS (analysts average ~1.4).
• Insider SVP Mischa Reis sold 9,675 shares at about $30 each (~$290K), reducing their stake by 23% to 32,382 shares; corporate insiders own roughly 0.99% of the stock.

Paradice Investment Management LLC lowered its stake in Envista Holdings Corporation (NYSE:NVST - Free Report) by 5.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,709,507 shares of the company's stock after selling 97,427 shares during the quarter. Envista comprises about 7.2% of Paradice Investment Management LLC's portfolio, making the stock its 3rd biggest holding. Paradice Investment Management LLC owned 1.04% of Envista worth $37,113,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of NVST. Farther Finance Advisors LLC raised its position in shares of Envista by 317.6% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company's stock worth $27,000 after buying an additional 1,026 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company's stock valued at $31,000 after acquiring an additional 1,504 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock valued at $44,000 after acquiring an additional 949 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Envista by 378.0% during the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company's stock valued at $47,000 after acquiring an additional 1,909 shares during the period. Finally, SJS Investment Consulting Inc. raised its holdings in Envista by 10,356.5% during the third quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company's stock worth $49,000 after purchasing an additional 2,382 shares in the last quarter.

Envista Price Performance

NYSE NVST opened at $27.06 on Friday. The stock has a market capitalization of $4.41 billion, a P/E ratio of 96.65, a P/E/G ratio of 1.85 and a beta of 0.98. Envista Holdings Corporation has a 1 year low of $15.49 and a 1 year high of $30.42. The business's fifty day moving average is $26.95 and its two-hundred day moving average is $23.65. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.The company's quarterly revenue was up 15.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, research analysts forecast that Envista Holdings Corporation will post 1.4 earnings per share for the current fiscal year.

Insider Activity at Envista

In other news, SVP Mischa Reis sold 9,675 shares of the company's stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the completion of the sale, the senior vice president directly owned 32,382 shares of the company's stock, valued at $971,460. This represents a 23.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.99% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Robert W. Baird set a $30.00 price target on Envista in a research note on Friday, February 6th. Evercore set a $30.00 target price on Envista in a research note on Wednesday, April 8th. UBS Group lifted their target price on Envista from $22.00 to $25.00 and gave the stock a "neutral" rating in a report on Tuesday, February 3rd. JPMorgan Chase & Co. boosted their price target on shares of Envista from $22.00 to $26.00 and gave the stock a "neutral" rating in a research report on Friday, February 6th. Finally, Zacks Research downgraded shares of Envista from a "strong-buy" rating to a "hold" rating in a report on Monday, April 6th. Seven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $27.69.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.